EZH2 is involved in regulation of cell cycle progression and dysregulation of EZH2 accelerates cell proliferation and promotes survival, resulting in cancer development, such as CRC, melanoma and breast cancer [20–22]. This evidence concerns the gene EZH2 and breast carcinoma.